datamatters24/research-document-archive huggingface dataset:
†
HR 2069 EAS
causes of the problem and its impact on families,
communities, and societal sectors.
(15) Basic interventions to prevent new HIV in-
fections and to bring care and treatment to people liv-
ing with AIDS, such as voluntary counseling and
testing and mother-to-child transmission programs,
are achieving meaningful results and are cost-effec-
tive. The challenge is to expand these interventions
from a pilot program basis to a national basis in a
coherent and sustainable manner.
(16) The magnitude and scope of the HIV/AIDS
crisis demands a comprehensive, long-term, inter-
national response focused upon addressing the causes,
reducing the spread, and ameliorating the con-
sequences of the HIV/AIDS pandemic, including—
(A) prevention and education, care and
treatment, basic and applied research, and
training of health care workers, particularly at
the community and provincial levels, and other
community workers and leaders needed to cope
with the range of consequences of the HIV/AIDS
crisis;
(B) development of health care infrastruc-
ture and delivery systems through cooperative
†
HR 2069 EAS
and coordinated public efforts and public and
private partnerships;
(C) development and implementation of na-
tional and community-based multisector strate-
gies that address the impact of HIV/AIDS on the
individual, family, community, and nation and
increase the participation of at-risk populations
in programs designed to encourage behavioral
and social change and reduce the stigma associ-
ated with HIV/AIDS; and
(D) coordination of efforts between inter-
national organizations such as the Global Fund
to Fight AIDS, Tuberculosis and Malaria, the
Joint United Nations Programme on HIV/AIDS
(UNAIDS), the World Health Organization
(WHO), national governments, and private sec-
tor organizations.
(17) The United States has the capacity to lead
and enhance the effectiveness of the international com-
munity’s response by—
(A) providing substantial financial re-
sources, technical expertise, and training, par-
ticularly of health care personnel and commu-
nity workers and leaders;
†
HR 2069 EAS
(B) promoting vaccine and microbicide re-
search and the development of new treatment
protocols in the public and commercial pharma-
ceutical research sectors;
(C) encouraging governments and commu-
nity-based organizations to adopt policies that
treat HIV/AIDS as a multisectoral problem af-
fecting not only health but other areas such as
education, the economy, the family and society,
and assisting them to develop and implement
programs corresponding to these needs; and
(D) encouraging active involvement of the
private sector, including businesses, pharma-
ceutical and biotechnology companies, the med-
ical and scientific communities, charitable foun-
dations, private and voluntary organizations
and nongovernmental organizations, faith-based
organizations, community-based organizations,
and other nonprofit entities.
SEC. 3. DEFINITIONS.
In this Act:
(1) AIDS.—The term ‘‘AIDS’’ means the ac-
quired immune deficiency syndrome.
(2) 
APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘appropriate congressional commit-
†
HR 2069 EAS
tees’’ means the Committee on Foreign Relations of
the Senate and the Committee on International Rela-
tions of the House of Representatives.
(3) 
DESIGNATED
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘designated congressional commit-
tees’’ means the Committee on Foreign Relations and
the Committee on Health, Education, Labor, and
Pensions of the Senate and the Committee on Inter-
national Relations and the Committee on Energy and
Commerce of the House of Representatives.
(4) GLOBAL FUND.—The term ‘‘Global Fund’’
means the public-private partnership known as the
Global Fund to Fight AIDS, Tuberculosis and Ma-
laria that was established upon the call of the United
Nations Secretary General in April 2001.
(5) HIV.—The term ‘‘HIV’’ means the human
immunodeficiency virus, the pathogen that causes
AIDS.
(6) HIV/AIDS.—The term ‘‘HIV/AIDS’’ means,
with respect to an individual, an individual who is
infected with HIV or living with AIDS.
(7) RELEVANT EXECUTIVE BRANCH AGENCIES.—
The term ‘‘relevant Executive branch agencies’’ means
the Department of State, the United States Agency for
International Development, the Department of Health
†
HR 2069 EAS
and Human Services (including the Centers for Dis-
ease Control and Prevention, the Health Resources
and Services Administration, the National Institutes
of Health, the Agency for Health Care Research and
Quality, and the Food and Drug Administration), the
Department of Labor, the Department of Commerce,
the Department of the Treasury, and the Department
of Defense.
SEC. 4. PURPOSE.
The purpose of this Act is to strengthen United States
leadership and the effectiveness of the United States re-
sponse to certain global infectious diseases by—
(1) establishing a comprehensive, integrated five-
year, global strategy to fight HIV/AIDS that encom-
passes a plan for phased expansion of critical pro-
grams and improved coordination among relevant
Executive branch agencies and between the United
States and foreign governments and international or-
ganizations;
(2) providing increased resources for multilateral
efforts to fight HIV/AIDS;
(3) providing increased resources for United
States bilateral efforts, particularly for technical as-
sistance and training, to combat HIV/AIDS, tuber-
culosis, and malaria;
†
HR 2069 EAS
(4) encouraging the expansion of private sector
efforts and expanding public-private sector partner-
ships to combat HIV/AIDS; and
(5) intensifying efforts to support the develop-
ment of vaccines and treatment for HIV/AIDS, tuber-
culosis, and malaria.
TITLE I—POLICY PLANNING AND
COORDINATION
SEC. 101. DEVELOPMENT OF A COMPREHENSIVE, FIVE-
YEAR, GLOBAL STRATEGY.
(a) STRATEGY.—The President shall establish a com-
prehensive, integrated, five-year strategy to combat global
HIV/AIDS that promotes the goals and objectives of the
Declaration of Commitment on HIV/AIDS, adopted by the
United Nations General Assembly at its Special Session on
HIV/AIDS in June 2001, and strengthens the capacity of
the United States to be an effective leader of the inter-
national campaign against HIV/AIDS. Such strategy
shall—
(1) include specific objectives, multisectoral ap-
proaches, and specific strategies to treat individuals
infected with HIV/AIDS and to prevent the further
spread of HIV infections, with a particular focus on
the needs of women, young people, and children;
†
HR 2069 EAS
(2) assign priorities for relevant Executive
branch agencies;
(3) improve coordination among relevant Execu-
tive branch agencies and foreign governments and
international organizations;
(4) project general levels of resources needed to
achieve the stated objectives;
(5) expand public-private partnerships and the
leveraging of resources; and
(6) maximize United States capabilities in the
areas of technical assistance and training and re-
search, including vaccine research.
(b) REPORT.—
(1) IN GENERAL.—Not later than 180 days after
the date of enactment of this Act, the President shall
submit to designated congressional committees a re-
port setting forth the strategy described in subsection
(a).
(2) REPORT ELEMENTS.—The report required by
paragraph (1) shall include a discussion of the fol-
lowing:
(A) The objectives, general and specific, of
the strategy.
(B) A description of the criteria for deter-
mining success of the strategy.
†
HR 2069 EAS
(C) A description of the manner in which
the strategy will address the fundamental ele-
ments of prevention and education; care and
treatment, including increasing access to phar-
maceuticals and to vaccines and microbicides
when available; research, including incentives for
vaccine development and new protocols; and
training of health care workers, and the develop-
ment of health care infrastructure and delivery
systems.
(D) A description of the manner in which
the strategy will promote the development and
implementation of national and community-
based multisectoral strategies and programs, in-
cluding those designed to enhance leadership ca-
pacity particularly at the community level.
(E) A description of the specific strategies
developed to meet the unique needs of women, in-
cluding the empowerment of women in inter-
personal situations, young people and children,
including those orphaned by HIV/AIDS.
(F) A description of the programs to be un-
dertaken to maximize United States contribu-
tions in the areas of technical assistance, train-
ing particularly of health care workers and com-
†
HR 2069 EAS
munity-based leaders in affected sectors, and re-
search including the promotion of research on
vaccines.
(G) An identification of the relevant Execu-
tive branch agencies that will be involved and
the assignment of priorities to those agencies.
(H) A description of the role of each rel-
evant Executive branch agency and the types of
programs that the agency will be undertaking.
(I) A description of the mechanisms that
will be utilized to coordinate the efforts of the
relevant Executive branch agencies, to avoid du-
plication of efforts, to enhance on-site coordina-
tion efforts, and to ensure that each agency un-
dertakes programs primarily in those areas
where the agency has the greatest expertise, tech-
nical capabilities, and potential for success.
(J) A description of the mechanisms that
will be utilized to ensure greater coordination be-
tween the United States and foreign governments
and international organizations including the
Global Fund, UNAIDS, international financial
institutions, and private sector organizations.
(K) The level of resources that will be need-
ed on an annual basis and the manner in which
†
HR 2069 EAS
those resources would generally be allocated
among relevant Executive agencies.
(L) A description of the mechanisms to be
established for monitoring and evaluating pro-
grams and for terminating unsuccessful pro-
grams.
(M) A description of the manner in which
private, nongovernmental entities will factor into
the United States Government-led effort and a
description of the type of partnerships that will
be created to maximize the capabilities of these
private sector entities and to leverage resources.
(N) A description of the manner in which
the United States strategy for combating HIV/
AIDS relates to and promotes the goals and ob-
jectives of the United Nations General Assembly’s
Declaration of Commitment on HIV/AIDS.
(O) A description of the ways in which
United States leadership will be used to enhance
the overall international response to the HIV/
AIDS pandemic and particularly to heighten the
engagement of the member states of the G–8 and
to strengthen key financial and coordination
mechanisms such as the Global Fund and
UNAIDS.
†
HR 2069 EAS
(P) A description of the manner in which
the United States strategy for combating HIV/
AIDS relates to and enhances other United
States assistance strategies in developing coun-
tries.
SEC. 102. COMPREHENSIVE PLAN TO EMPOWER WOMEN TO
PREVENT THE SPREAD OF HIV/AIDS.
(a) STATEMENT OF POLICY.—It is in the national in-
terest of the United States—
(1) to assist in empowering women socially, eco-
nomically, and intellectually to prevent coercive prac-
tices which contribute to the spread of HIV/AIDS;
(2) to ensure that there are affordable effective fe-
male controlled preventative technologies widely avail-
able;
(3) to assist in providing adequate pre- and
post-natal care to women infected with HIV or living
with AIDS to prevent an increase in the number of
AIDS orphans; and
(4) to educate communities in order to lessen the
stigma facing women who are infected with HIV or
living with AIDS.
(b) DEVELOPMENT
OF PLAN.—The United States
Agency for International Development, working in conjunc-
tion with other relevant Executive branch agencies, shall
†
HR 2069 EAS
develop a comprehensive plan to empower women to protect
themselves against the spread of HIV/AIDS. The plan shall
include—
(1) immediately providing women greatly in-
creased access to and program support for currently
available prevention technologies for women and
microbicides when they become available;
(2) providing funding for research to develop
safe, effective, usable microbicides, including support
for—
(A) development and preclinical evaluation
of topical microbicides;
(B) the conduct of clinical studies of can-
didate microbicides to assess safety, accept-
ability, and effectiveness in reducing the HIV in-
fection and other sexually transmitted infections;
(C) behavioral and social science research
relevant to microbicide development, testing, ac-
ceptability, and use; and
(D) introductory studies of safe and effective
microbicides in developing countries;
(3) increasing women’s access to microfinance
programs;
(4) comprehensive education for women and girls
including health education that emphasizes skills
†
HR 2069 EAS
building on negotiation and the prevention of sexu-
ally transmitted infections and other related repro-
ductive health risks and strategies that emphasize the
delay of sexual debut;
(5) community-based strategies to combat gen-
der-based violence and sexual coercion of women and
minors;
(6) expansion of peer education strategies for
men which emphasize responsible sexual behavior and
consultation with their wives and partners in making
decisions about sex and reproduction;
(7) resources for households headed by females
caring for AIDS orphans;
(8) followup monitoring of and care and support
for post-natal women living with HIV or at high risk
of infection; and
(9) targeted plans to reduce the vulnerability of
HIV/AIDS for women, young people, and children
who are refugees or internally displaced persons.
(c) REQUIREMENT.—The plan shall specify, for the as-
sistance to achieve each of the objectives set forth in para-
graphs (1) through (9) of subsection (b), the section of the
Foreign Assistance Act of 1961 or other law that authorizes
such assistance.
†
HR 2069 EAS
(d) STAFFING.—The Administrator of the United
States Agency for International Development shall ensure
that the Agency dedicates a sufficient number of employees
to implementing the plan described in subsection (b).
(e) REPORT.—Not later than 270 days after the date
of enactment of this Act and every year for the next 3 years
thereafter, the Administrator of the United States Agency
for International Development shall submit to the appro-
priate congressional committees a report on the plan being
implemented by the United States Agency for International
Development on empowering women in order to prevent the
spread of HIV/AIDS. The report shall include a description
of—
(1) the programs being carried out that are spe-
cifically targeted at women and girls to educate them
about the spread of HIV/AIDS and the use and avail-
ability of currently available prevention technologies
for women, together with the number of women and
girls reached through these programs;
(2) the steps taken to increase the availability of
such technologies; and
(3) the progress on developing a safe, effective,
user-friendly microbicide.
II
Calendar No. 434
107TH CONGRESS
2D SESSION
H.R. 2068
IN THE SENATE OF THE UNITED STATES
JUNE 12, 2002
Received; read twice and referred to the Committee on the Judiciary
JUNE 21, 2002
Reported by Mr. LEAHY, without amendment
AN ACT
To revise, codify, and enact without substantive change cer-
tain general and permanent laws, related to public build-
ings, property, and works, as title 40, United States
Code, ‘‘Public Buildings, Property, and Works’’.
Be it enacted by the Senate and House of Representatives of the United
States of America in Congress assembled,
SECTION 1. TITLE 40, UNITED STATES CODE.
Certain general and permanent laws of the United States, related to pub-
lic buildings, property, and works, are revised, codified, and enacted as title
40, United States Code, ‘‘Public Buildings, Property, and Works’’, as fol-
lows:
TITLE 40—PUBLIC BUILDINGS,
PROPERTY, AND WORKS
SUBTITLE
Sec.
I.
FEDERAL PROPERTY AND ADMINISTRATIVE SERVICES ................
101
II.
PUBLIC BUILDINGS AND WORKS ...........................................................
3101
†
HR 2069 EAS
‘‘(d) REPORTS.—Not later than 6 months after the
date of enactment of this section, and annually thereafter,
an administrative organization awarded a grant under
subsection (b)(1) shall submit to the Secretary and the ap-
propriate committees of Congress, a report that includes—
‘‘(1) the progress of programs funded under this
section;
‘‘(2) the benchmarks of success of programs fund-
ed under this section; and
‘‘(3) recommendations of how best to proceed
with the programs funded under this section upon the
expiration of funding under subsection (e).
‘‘(e) FUNDING.—In making amounts available under
section 399AA(f) to carry out this section, the Secretary
shall ensure that not less than—
‘‘(1) $45,000,000 is made available to carry out
this section for fiscal year 2003; and
‘‘(2) $30,000,000 is made available to carry out
this section for fiscal year 2004.
‘‘(f) LIMITATION ON ADMINISTRATIVE EXPENSES.—An
administrative organization shall ensure that not more
than 12 percent of the amount of a grant received under
this section by the organization is used for the administra-
tive activities described in subparagraphs (B), (C), (D),
and (E) of subsection (b)(3) and subsection (b)(5)(E).
†
HR 2069 EAS
SEC. 103. HIV/AIDS RESPONSE COORDINATOR.
(a) ESTABLISHMENT OF POSITION.—Section 1 of the
State Department Basic Authorities Act of 1956 (22 U.S.C.
265(a)) is amended—
(1) by redesignating subsections (f) and (g) as
subsections (g) and (h), respectively; and
(2) by adding after subsection (e) the following:
‘‘(f) HIV/AIDS RESPONSE COORDINATOR.—
‘‘(1) IN GENERAL.—There shall be within the De-
partment of State a Coordinator of United States
Government Activities to Combat HIV/AIDS Glob-
ally, who shall be appointed by the President, by and
with the advice and consent of the Senate. The Coor-
dinator shall report directly to the Secretary of State
and shall have the rank and status of ambassador.
‘‘(2) DUTIES.—
‘‘(A) IN GENERAL.—The Coordinator shall
have primary responsibility for the oversight and
coordination of all activities of the United States
Government to combat the international HIV/
AIDS 
pandemic, 
including 
all 
programs,
projects, and activities of the United States Gov-
ernment under titles I through V of the United
States Leadership Against HIV/AIDS, Tuber-
culosis, and Malaria Act of 2002 or any amend-
ment made by those titles.
†
HR 2069 EAS
‘‘(B) SPECIFIC DUTIES.—The duties of the
Coordinator shall specifically include the fol-
lowing:
‘‘(i) Ensuring program and policy co-
ordination among the relevant Executive
branch agencies.
‘‘(ii) Ensuring that each relevant Exec-
utive branch agency undertakes programs
primarily in those areas where the agency
has the greatest expertise, technical capa-
bilities, and potential for success.
‘‘(iii) Avoiding duplication of effort.
‘‘(iv) Enhancing onsite coordination.
‘‘(v) Pursuing coordination with other
countries and international organizations.
‘‘(vi) Resolving policy, program, and
funding disputes among the relevant Execu-
tive branch agencies.’’.
(b) FIRST COORDINATOR.—The President may des-
ignate the incumbent Special Representative of the Sec-
retary of State for HIV/AIDS as of the date of enactment
of this Act as the first Coordinator of United States Govern-
ment Activities to Combat HIV/AIDS Globally.
†
HR 2069 EAS
SEC. 104. REPORT ON REVERSING THE EXODUS OF CRIT-
ICAL TALENT.
(a) IN GENERAL.—Not later than one year after the
date of enactment of this Act, the President shall submit
a report to designated congressional committees analyzing
the emigration of critically important medical and public
health personnel, including physicians, nurses, and super-
visors from sub-Saharan African countries that are acutely
impacted by HIV/AIDS.
(b) ELEMENTS OF THE REPORT.—The report shall
include—
(1) an analysis of the causes for the exodus of
such personnel, the present and projected trend lines,
and the impact on the stability of health infrastruc-
tures; and
(2) a description of incentives and programs
that the United States could provide, in concert with
other private and public sector partners and inter-
national organizations, to stabilize health institutions
by encouraging critical personnel to remain in their
home countries.
TITLE II—PUBLIC-PRIVATE
PARTNERSHIPS
SEC. 201. SENSE OF CONGRESS ON PUBLIC-PRIVATE PART-
NERSHIPS.
(a) FINDINGS.—Congress makes the following findings:
†
HR 2069 EAS
(1) Innovative partnerships between governments
and organizations in the private sector (including
foundations, universities, corporations, faith-based
and community-based organizations, and other non-
governmental organizations) have proliferated in re-
cent years, particularly in the area of health.
(2) Public-private sector partnerships multiply
local and international capacities to strengthen the
delivery of health services in developing countries and
to accelerate research for vaccines and other pharma-
ceutical products that are essential to combat infec-
tious diseases decimating the populations of these
countries.
(3) These partnerships maximize the unique ca-
pabilities of each sector while combining financial
and other resources, scientific knowledge, and exper-
tise toward common goals which neither the public
nor the private sector can achieve alone.
(4) Sustaining existing public-private partner-
ships and building new ones are critical to the success
of the international community’s efforts to combat
HIV/AIDS and other infectious diseases around the
globe.
(b) SENSE OF CONGRESS.—It is the sense of Congress
that—
†
HR 2069 EAS
(1) the sustainment and promotion of public-pri-
vate partnerships should be a priority element of the
strategy pursued by the United States to combat the
HIV/AIDS pandemic and other global health crises;
and
(2) the United States should systematically track
the evolution of these partnerships and work with oth-
ers in the public and private sector to profile and
build upon those models that are most effective.
SEC. 202. PARTICIPATION IN THE GLOBAL FUND TO FIGHT
AIDS, TUBERCULOSIS, AND MALARIA.
(a) AUTHORITY
FOR UNITED STATES PARTICIPA-
TION.—
(1) 
UNITED
STATES
PARTICIPATION.—The
United States is hereby authorized to participate in
the Global Fund to Fight AIDS, Tuberculosis and
Malaria.
(2) PRIVILEGES AND IMMUNITIES.—The Global
Fund shall be considered a public international orga-
nization for purposes of section 1 of the International
Organizations Immunities Act (22 U.S.C. 288).
(b) REPORTS TO CONGRESS.—Not later than one year
after the date of the enactment of this Act, and annually
thereafter for the duration of the Global Fund, the President
shall submit to the appropriate congressional committees a
†
HR 2069 EAS
report on the Global Fund, including contributions pledged,
contributions received (including donations from the pri-
vate sector), projects funded, and the mechanisms estab-
lished for transparency and accountability in the grant
making process.
(c) UNITED STATES FINANCIAL PARTICIPATION.—
(1) AUTHORIZATION
OF
APPROPRIATIONS.—In
addition to funds otherwise available for such pur-
pose, there are authorized to be appropriated to the
President $1,000,000,000 for the fiscal year 2003 and
$1,200,000,000 for the fiscal year 2004 for contribu-
tions to the Global Fund.
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to paragraph (1) are authorized to
remain available until expended.
(3) REPROGRAMMING
OF
FISCAL
YEAR
2001
FUNDS.—Funds made available for fiscal year 2001
under section 141 of the Global AIDS and Tuber-
culosis Relief Act of 2000—
(A) are authorized to remain available until
expended; and
(B) shall be transferred to, merged with,
and made available for the same purposes as,
funds made available for fiscal year 2002 under
paragraph (1).